Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trials (English, HTML)

View metadata and access the original English HTML file: Canada’s regulatory approach to drugs for rare diseases: apply and register for clinical trials.

Format

HTML

Access

file-only

Publisher-reported update

2023-12-02

Health Canada’s Therapeutic Products Directorate (TPD) and Biologics and Genetic Therapies Directorate (BGTD) are responsible for reviewing the applications for authorization to sell or import drugs for the purposes of conducting clinical trials in Canada.

Access original file